Nearly a decade of research to solve a common eye ailment paid off for Encore Vision in Fort Worth.
The company, founded by Alcon Laboratories veteran Bill Burns, has been acquired by pharmaceutical giant Novartis, the Swiss company that also owns Alcon.
The acquisition comes just as Encore Vision prepares to bring a topical eye treatment to market. Financial details were not disclosed.
The eye drops will be used to treat presbyopia, a condition that most people get as they age that makes it harder for them to focus their eyes. Clinical tests have shown it can improve vision over three months.
Encore Vision is based at TECH Fort Worth, a nonprofit that helps entrepreneurs grow their companies. Encore Vision received the largest single investment, $1.25 million, from the Cowtown Angels, the investors who founded TECH Fort Worth.
Delivering what’s new and next in Dallas-Fort Worth innovation, every day. Get the Dallas Innovates e-newsletter.
R E A D N E X T
-
The optical technology startup aims to improve the lives of millions of people suffering from severe vision loss due to macular degeneration or diabetes. It was one of 50 selected for MedTech Innovator's 2019 Accelerator and Showcase program—and the only one from North Texas—out of 800 applicants.
-
The survey behind the report included 6,381 international business and IT executives including those from Dallas, Atlanta, Boston, Chicago, Houston, New York City, and San Francisco.
-
Here are notable organizations that veterans of the eye care giant have started or hold executive positions in.
-
This alum of Dallas startup accelerator Health Wildcatters is working with the National Cancer Institute's Developmental Therapeutics Branch on precision research and treatments.
-
In this weekly roundup of executive and leadership moves by companies and organizations in North Texas, you'll also find news from Colonial Savings, Crawford & Co., Kubota, North Dallas Bank & Trust Co., Amy Stewart Law, and Communities Foundation of Texas.
Comments are closed.